290 related articles for article (PubMed ID: 17548480)
21. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor.
Steele C; Marrero L; Swain S; Harmsen AG; Zheng M; Brown GD; Gordon S; Shellito JE; Kolls JK
J Exp Med; 2003 Dec; 198(11):1677-88. PubMed ID: 14657220
[TBL] [Abstract][Full Text] [Related]
22. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation.
Koziel H; Eichbaum Q; Kruskal BA; Pinkston P; Rogers RA; Armstrong MY; Richards FF; Rose RM; Ezekowitz RA
J Clin Invest; 1998 Oct; 102(7):1332-44. PubMed ID: 9769325
[TBL] [Abstract][Full Text] [Related]
23. Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice.
Wright TW; Johnston CJ; Harmsen AG; Finkelstein JN
Am J Respir Cell Mol Biol; 1997 Oct; 17(4):491-500. PubMed ID: 9376124
[TBL] [Abstract][Full Text] [Related]
24. Activation and suppression of natural cellular immune functions by Pneumocystis carinii.
Warschkau H; Yu H; Kiderlen AF
Immunobiology; 1998 Feb; 198(4):343-60. PubMed ID: 9562861
[TBL] [Abstract][Full Text] [Related]
25. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts.
Lasbury ME; Tang X; Durant PJ; Lee CH
Infect Immun; 2003 Sep; 71(9):4943-52. PubMed ID: 12933836
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model.
Shellito JE; Kolls JK; Olariu R; Beck JM
J Infect Dis; 1996 Feb; 173(2):432-9. PubMed ID: 8568306
[TBL] [Abstract][Full Text] [Related]
27. Pneumocystis carinii induction of tumor necrosis factor-alpha by alveolar macrophages: modulation by pentamidine isethionate.
Corsini E; Dykstra C; Craig WA; Tidwell RR; Rosenthal GJ
Immunol Lett; 1992 Dec; 34(3):303-8. PubMed ID: 1487315
[TBL] [Abstract][Full Text] [Related]
28. Neonatal T cells in an adult lung environment are competent to resolve Pneumocystis carinii pneumonia.
Qureshi MH; Garvy BA
J Immunol; 2001 May; 166(9):5704-11. PubMed ID: 11313412
[TBL] [Abstract][Full Text] [Related]
29. The Interaction of
Kottom TJ; Hebrink DM; Jenson PE; Nandakumar V; Wüthrich M; Wang H; Klein B; Yamasaki S; Lepenies B; Limper AH
J Immunol; 2017 May; 198(9):3515-3525. PubMed ID: 28298521
[No Abstract] [Full Text] [Related]
30. A critical role for CARD9 in pneumocystis pneumonia host defence.
Kottom TJ; Nandakumar V; Hebrink DM; Carmona EM; Limper AH
Cell Microbiol; 2020 Oct; 22(10):e13235. PubMed ID: 32548948
[TBL] [Abstract][Full Text] [Related]
31. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism.
Hoffman OA; Standing JE; Limper AH
J Immunol; 1993 May; 150(9):3932-40. PubMed ID: 8386203
[TBL] [Abstract][Full Text] [Related]
32. Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages.
Lasbury ME; Lin P; Tschang D; Durant PJ; Lee CH
Infect Immun; 2004 Apr; 72(4):2140-7. PubMed ID: 15039336
[TBL] [Abstract][Full Text] [Related]
33. Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.
Wang J; Gigliotti F; Bhagwat SP; George TC; Wright TW
PLoS Pathog; 2010 Aug; 6(8):e1001058. PubMed ID: 20808846
[TBL] [Abstract][Full Text] [Related]
34. B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection.
Lund FE; Hollifield M; Schuer K; Lines JL; Randall TD; Garvy BA
J Immunol; 2006 May; 176(10):6147-54. PubMed ID: 16670323
[TBL] [Abstract][Full Text] [Related]
35. Pneumocystis carinii factor responsible for reduced phagocytic activity in alveolar macrophages.
Lasbury ME; Lin PM; Tschang D; Durant PJ; Lee CH
J Eukaryot Microbiol; 2003; 50 Suppl():641-2. PubMed ID: 14736197
[No Abstract] [Full Text] [Related]
36. Numbers of alveolar macrophages are increased during Pneumocystis pneumonia in mice.
Lasbury ME; Durant PJ; Lee CH
J Eukaryot Microbiol; 2003; 50 Suppl():637-8. PubMed ID: 14736195
[No Abstract] [Full Text] [Related]
37. Cellular and cytokine changes in the alveolar environment among immunocompromised patients during Pneumocystis jirovecii infection.
Iriart X; Witkowski B; Courtais C; Abbes S; Tkaczuk J; Courtade M; Cassaing S; Fillaux J; Blancher A; Magnaval JF; Pipy B; Berry A
Med Mycol; 2010 Dec; 48(8):1075-87. PubMed ID: 20470237
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor 2 knockout reduces lung inflammation during Pneumocystis pneumonia but has no effect on phagocytosis of Pneumocystis organisms by alveolar macrophages.
Zhang C; Wang SH; Liao CP; Lasbury ME; Durant PJ; Tschang D; Lee CH
J Eukaryot Microbiol; 2006; 53 Suppl 1():S132-3. PubMed ID: 17169030
[No Abstract] [Full Text] [Related]
39. Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro.
Zhang J; Tachado SD; Patel N; Zhu J; Imrich A; Manfruelli P; Cushion M; Kinane TB; Koziel H
J Leukoc Biol; 2005 Sep; 78(3):665-74. PubMed ID: 16000387
[TBL] [Abstract][Full Text] [Related]
40. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-alpha in response to Pneumocystis carinii.
Neese LW; Standing JE; Olson EJ; Castro M; Limper AH
J Immunol; 1994 May; 152(9):4549-56. PubMed ID: 7512599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
